Would you recommend use of ESA for anemia of kidney disease in the setting of metastatic solid tumor malignancy?
Community PollStarted
Do you feel comfortable recommending ESAs for anemia of chronic disease in patients with metastatic/incurable solid tumors?
10 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet MemberInvited Expert
Hematology · Indiana University
Answered on
It is not unreasonable in CKD patients with symptomatic anemia and a non-curable metastatic cancer to consider using an ESA. However, this requires an extensive discussion with the patient. ASCO/ASH guidelines recommend against the use of these agents in patients with curable malignancies, so if the...
Join for free or sign in to see the full answer